Connecticut Coastal Metabolism, Llc - Medicare Primary Care in Milford, CT

Connecticut Coastal Metabolism, Llc is a medicare enrolled primary clinic (Internal Medicine - Endocrinology, Diabetes & Metabolism) in Milford, Connecticut. The current practice location for Connecticut Coastal Metabolism, Llc is 2068 Bridgeport Ave, Milford, Connecticut. For appointments, you can reach them via phone at (203) 701-6787. The mailing address for Connecticut Coastal Metabolism, Llc is 2068 Bridgeport Ave, Milford, Connecticut and phone number is (203) 701-6787.

Connecticut Coastal Metabolism, Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1730702705. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (203) 701-6787.

Contact Information

Connecticut Coastal Metabolism, Llc
2068 Bridgeport Ave
Milford
CT 06460-4634
(203) 701-6787
(203) 693-2955

Primary Care Clinic Profile

Full NameConnecticut Coastal Metabolism, Llc
SpecialityInternal Medicine
Location2068 Bridgeport Ave, Milford, Connecticut
Authorized Official Name and PositionSusan Wang (PRACTICE OWNER)
Authorized Official Contact2037016787
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Connecticut Coastal Metabolism, Llc
2068 Bridgeport Ave
Milford
CT 06460-4634

Ph: (203) 701-6787
Connecticut Coastal Metabolism, Llc
2068 Bridgeport Ave
Milford
CT 06460-4634

Ph: (203) 701-6787

NPI Details:

NPI Number1730702705
Provider Enumeration Date05/25/2020
Last Update Date05/25/2020

Medicare PECOS Information:

Medicare PECOS PAC ID9032535752
Medicare Enrollment IDO20200729002887

News Archive

Trump administration, pharma exchange verbal volleys on drug-price transparency

The Trump administration and drugmakers are squaring off over a proposal to show drug prices in television ads.

LCA-GA calls on entire Georgia delegation to support Lung Cancer Mortality Reduction Act

Today, Lung Cancer Alliance-Georgia (LCA-GA) thanked Senator Johnny Isakson (R-GA) for being an original sponsor of the Lung Cancer Mortality Reduction Act (S. 752), authorizing legislation that establishes a multi-agency, comprehensive research program addressing all aspects of lung cancer, and called on the entire delegation of Georgia to show their support for the lung cancer community.

Children treated for soft tissue sarcomas at greater risk of second cancers

A new study has found that although children treated for soft tissue sarcomas are surviving longer than they did in the past, they have an increased risk for second cancers, especially when initial treatment combined radiation and chemotherapy. This is according to analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.

Industry experts to discuss best practices in healthcare operations at 2009 HFMA Revenue Cycle Strategies Conference

Craneware, Inc. (AIM: CRW.L), a leader in financial performance improvement solutions for U.S. healthcare, today announced a presentation at the Healthcare Financial Management Association's (HFMA) Revenue Cycle Strategies Conference scheduled for November 5-7 in Chicago, IL.

Has COVID-19 vaccine confidence dropped following the pause of Johnson & Johnson/Janssen?

A new study, which was conducted by Vishala Mishra and Joseph P. Dexter at Madras Medical College, Chennai, India, suggests that the infamous pause in the administration of the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine, advised by the FDA, has left doubt about the veracity of vaccine safety claims. This is a development that may have engendered vaccine hesitancy in a segment of the population.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Connecticut Coastal Metabolism, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1730702705NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RE0101XInternal Medicine - Endocrinology, Diabetes & Metabolism (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Connecticut Coastal Metabolism, Llc acts as a billing entity for following providers:
Provider NameSusan M Wang
Provider TypePractitioner - Endocrinology
Provider IdentifiersNPI Number: 1598880031
PECOS PAC ID: 0840388955
Enrollment ID: I20071126000487

News Archive

Trump administration, pharma exchange verbal volleys on drug-price transparency

The Trump administration and drugmakers are squaring off over a proposal to show drug prices in television ads.

LCA-GA calls on entire Georgia delegation to support Lung Cancer Mortality Reduction Act

Today, Lung Cancer Alliance-Georgia (LCA-GA) thanked Senator Johnny Isakson (R-GA) for being an original sponsor of the Lung Cancer Mortality Reduction Act (S. 752), authorizing legislation that establishes a multi-agency, comprehensive research program addressing all aspects of lung cancer, and called on the entire delegation of Georgia to show their support for the lung cancer community.

Children treated for soft tissue sarcomas at greater risk of second cancers

A new study has found that although children treated for soft tissue sarcomas are surviving longer than they did in the past, they have an increased risk for second cancers, especially when initial treatment combined radiation and chemotherapy. This is according to analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.

Industry experts to discuss best practices in healthcare operations at 2009 HFMA Revenue Cycle Strategies Conference

Craneware, Inc. (AIM: CRW.L), a leader in financial performance improvement solutions for U.S. healthcare, today announced a presentation at the Healthcare Financial Management Association's (HFMA) Revenue Cycle Strategies Conference scheduled for November 5-7 in Chicago, IL.

Has COVID-19 vaccine confidence dropped following the pause of Johnson & Johnson/Janssen?

A new study, which was conducted by Vishala Mishra and Joseph P. Dexter at Madras Medical College, Chennai, India, suggests that the infamous pause in the administration of the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine, advised by the FDA, has left doubt about the veracity of vaccine safety claims. This is a development that may have engendered vaccine hesitancy in a segment of the population.

Read more Medical News

› Verified 4 days ago

Provider NameRosanna Maria M Mendite
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1295200020
PECOS PAC ID: 8224373436
Enrollment ID: I20181217001582

News Archive

Trump administration, pharma exchange verbal volleys on drug-price transparency

The Trump administration and drugmakers are squaring off over a proposal to show drug prices in television ads.

LCA-GA calls on entire Georgia delegation to support Lung Cancer Mortality Reduction Act

Today, Lung Cancer Alliance-Georgia (LCA-GA) thanked Senator Johnny Isakson (R-GA) for being an original sponsor of the Lung Cancer Mortality Reduction Act (S. 752), authorizing legislation that establishes a multi-agency, comprehensive research program addressing all aspects of lung cancer, and called on the entire delegation of Georgia to show their support for the lung cancer community.

Children treated for soft tissue sarcomas at greater risk of second cancers

A new study has found that although children treated for soft tissue sarcomas are surviving longer than they did in the past, they have an increased risk for second cancers, especially when initial treatment combined radiation and chemotherapy. This is according to analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.

Industry experts to discuss best practices in healthcare operations at 2009 HFMA Revenue Cycle Strategies Conference

Craneware, Inc. (AIM: CRW.L), a leader in financial performance improvement solutions for U.S. healthcare, today announced a presentation at the Healthcare Financial Management Association's (HFMA) Revenue Cycle Strategies Conference scheduled for November 5-7 in Chicago, IL.

Has COVID-19 vaccine confidence dropped following the pause of Johnson & Johnson/Janssen?

A new study, which was conducted by Vishala Mishra and Joseph P. Dexter at Madras Medical College, Chennai, India, suggests that the infamous pause in the administration of the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine, advised by the FDA, has left doubt about the veracity of vaccine safety claims. This is a development that may have engendered vaccine hesitancy in a segment of the population.

Read more Medical News

› Verified 4 days ago

News Archive

Trump administration, pharma exchange verbal volleys on drug-price transparency

The Trump administration and drugmakers are squaring off over a proposal to show drug prices in television ads.

LCA-GA calls on entire Georgia delegation to support Lung Cancer Mortality Reduction Act

Today, Lung Cancer Alliance-Georgia (LCA-GA) thanked Senator Johnny Isakson (R-GA) for being an original sponsor of the Lung Cancer Mortality Reduction Act (S. 752), authorizing legislation that establishes a multi-agency, comprehensive research program addressing all aspects of lung cancer, and called on the entire delegation of Georgia to show their support for the lung cancer community.

Children treated for soft tissue sarcomas at greater risk of second cancers

A new study has found that although children treated for soft tissue sarcomas are surviving longer than they did in the past, they have an increased risk for second cancers, especially when initial treatment combined radiation and chemotherapy. This is according to analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.

Industry experts to discuss best practices in healthcare operations at 2009 HFMA Revenue Cycle Strategies Conference

Craneware, Inc. (AIM: CRW.L), a leader in financial performance improvement solutions for U.S. healthcare, today announced a presentation at the Healthcare Financial Management Association's (HFMA) Revenue Cycle Strategies Conference scheduled for November 5-7 in Chicago, IL.

Has COVID-19 vaccine confidence dropped following the pause of Johnson & Johnson/Janssen?

A new study, which was conducted by Vishala Mishra and Joseph P. Dexter at Madras Medical College, Chennai, India, suggests that the infamous pause in the administration of the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine, advised by the FDA, has left doubt about the veracity of vaccine safety claims. This is a development that may have engendered vaccine hesitancy in a segment of the population.

Read more News

› Verified 4 days ago


Internal Medicine in Milford, CT

Dr. John Katsetos Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 353 Bridgeport Avenue, Milford, CT 06460
Phone: 203-877-1212    Fax: 203-877-1211
Dean Har Md Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 2044 Bridgeport Ave Ste B, Milford, CT 06460
Phone: 203-298-9191    Fax: 203-298-9194
Bridges Primary Care Center
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 949 Bridgeport Ave, Milford, CT 06460
Phone: 203-878-6365    Fax: 203-683-3615
Stravada Wellness Care Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 203 Broad St Unit C-4, Milford, CT 06460
Phone: 413-218-9839    
Steven L. Saunders, M.d., Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 849 Boston Post Rd Ste 102, Milford, CT 06460
Phone: 203-878-6848    Fax: 203-876-6852
Genesis Medica Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 247 Broad Street, Milford, CT 06460
Phone: 203-693-2230    Fax: 203-693-2232
Seby Jacob Md, Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2047 Bridgeport Ave, Milford, CT 06460
Phone: 203-876-4325    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.